Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents. Use with caution in patients receiving such agents.
Source: NLP:clindamycin phosphate topical solution usp, 1%
Clindamycin Phosphate Topical Solution Usp, 1% Interactions
Brand names: Clindamycin Phoaphate Topical Solution Usp, 1%
Route: Topical
Contraindications
CONTRAINDICATIONS Clindamycin phosphate topical solution USP, 1% is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis.
Pregnancy & Breastfeeding
Pregnancy Teratogenic effects In clinical trials with pregnant women, the systemic administration of clindamycin during the second and third trimesters has not been associated with an increased frequency of congenital abnormalities. There are no adequate studies in pregnant women during the first trimester of pregnancy. Clindamycin should be used during the first trimester of pregnancy only if clearly needed.
2 interactions on record
Drug Interactions Clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents.
Source: FDA drug label - clindamycin phosphate topical solution usp, 1%